J&J | Capitaux D'Emprunt



Loan Capital Changement Date
AbbVie USD 60.34B 1.83B 2024-12
Abbott USD 12.74B 111M 2025-03
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Baxter International USD 10.37B 63M 2024-12
Bayer EUR 35.02B 468M 2025-03
Becton, Dickinson and Co. USD 17.67B 226M 2025-03
Biogen USD 4.55B 1.4M 2024-12
Boston Scientific USD 10.53B 1.56B 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
CONMED USD 891.44M 13.62M 2025-03
Cooper Companies USD 2.49B 59.2M 2025-01
Dexcom USD 1.3B 100K 2025-03
Edwards Lifesciences USD 597.7M 200K 2024-12
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Globus Medical USD 257K 41K 2025-03
Hologic USD 2.47B 18.8M 2025-03
Indivior 311M 4M 2025-03
Insulet USD 1.61B 316.2M 2025-03
Integra LifeSciences USD 1.23B 34.62M 2025-03
Intuitive Surgical USD 0 0 2025-03
J&J USD 38.36B 7.7B 2025-03
Medtronic USD 25.64B 1.66B 2025-04
Merck USD 33.48B 978M 2025-03
Merit Medical Systems USD 730.67M 1.12M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.64B 234M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
Stryker USD 14.38B 2.2B 2025-03
Tandem Diabetes Care USD 313.6M 5.34M 2025-03
Teva Pharmaceutical Industries USD 16.23B 228M 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zimmer Biomet Holdings USD 5.34B 603.9M 2024-12
Zoetis USD 5.23B 7M 2025-03



J&J Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.